Daily low-dose subcutaneous recombinant interleukin-2 by alternate weekly administration: antitumor activity and immunomodulatory effects.
暂无分享，去创建一个
P. Tagliaferri | M. Caraglia | E. Matano | A. Bianco | P. Correale | G. Palmieri | C. Barile | R. Guarrasi | M. Librera | A. Martignetti | A. Della Vecchia | D. Morelli | B. Ricciardi | G. Catalano | M. Famiani